Form C - Offering Statement:
SEC Accession No. 0001910093-22-000003
Filing Date
2022-03-01
Accepted
2022-03-01 16:24:00
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 10113
2 SMARTSAFE AND PROXY AGREEMENT AT-SmartSAFE.pdf EX-99 397197
3 ARTICLES OF INCORPORATION AT-Articles.pdf EX-99 787136
4 FINANCIAL REVIEW AND DISCLOSURE AT-Financials.pdf EX-99 141618
5 PITCH DECK AT-PitchDeck1.pdf EX-99 9383797
6 FAST PITCH AT-FastPitch.pdf EX-99 5424895
7 OFFERING STATEMENT AT-Offering.pdf EX-99 20314894
8 PITCH PAGE AT-PitchPage.pdf EX-99 7897649
  Complete submission text file 0001910093-22-000003.txt   61057385
Mailing Address 1375 BRIDGE RD EASTHAM MA 02642
Business Address 1375 BRIDGE RD EASTHAM MA 02642 6178217095
Akttyva Therapeutics, Inc. (Filer) CIK: 0001910093 (see all company filings)

EIN.: 853622845 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-29786 | Film No.: 22698432